Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc XRTX


Primary Symbol: V.XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

Bullboard (TSXV:XRTX)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by moneywinner1on Jun 08, 2022 10:44am

After good news there is bad one

Is travels are tooo expensive, get davidof to work and show the work not travel to see investors . Are you looking for financing and dilution you mf 
128
Discussion
Post by moneywinner1on Jun 07, 2022 1:56pm

Xrtx on Nasdaq is up 16% now

Tsx on canafian side  has lower volume and only 6% wow you cCsnadians 
132
Comment by moneywinner1on Jun 07, 2022 1:31pm

RE:On Nasdaq is 10% already

Converted Nasdaq price to Canadian dollar it trades at $2.12 Canadian 
65
Discussion
Post by moneywinner1on Jun 07, 2022 12:40pm

On Nasdaq is 10% already

Let's see $2 next trade on Canadian side , 
145
Discussion
Post by moneywinner1on Jun 07, 2022 12:33pm

Price crossed 21 day moving average

This one is $5 back in a week 
90
Post by moneywinner1on Jun 07, 2022 12:32pm

On Nasdaq is up 7% , tsx trades down 2.5%

Something has to give, I go with Nasdaq trades and like it 
71
Post by moneywinner1on Jun 07, 2022 11:25am

Starting run , today again 30-30% up?

At Nasdaq is up 9% already. 
78
Discussion
Comment by moneywinner1on Jun 07, 2022 10:23am

RE:RE:RE:RE:This news should have 50% gain

Look at Nasdaq is up 9% already this morning, 
72
Discussion
Comment by lscfaon Jun 07, 2022 9:27am

RE:Strong BUY initiated, now 1.80 target $17.50

It's a BS lie without a link. Alliance has a $11 cdn tp. https://europac.bluematrix.com/sellside/EmailDocViewer?encrypt=3d118b2d-89c3-40dc-b38e-8ba0270761f3&mime=pdf&co=Europac&id ...more  
124
Discussion
Comment by moneywinner1on Jun 07, 2022 9:20am

RE:RE:RE:This news should have 50% gain

All shareholders were expecting this addition to the company . Now news on USA drug approval and this is going well into target . $17.50 USA 
101
Discussion
Comment by moneywinner1on Jun 06, 2022 11:37pm

RE:Strong BUY initiated, now 1.80 target $17.50

Strong BUY initiated, now 1.80 target $17.50 XRTX Analyst Research XRTX Analyst Ratings CONSENSUSStrong Buy target price $17.50 USD 
136
Discussion
Comment by Anklebiter42on Jun 06, 2022 11:08pm

RE:Hello again, no value stock

What happened to this guy? Haha. I guess you had to take a different path than the rest of us. Either way, happy you were able to hold on. 
63
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities